Review Strut’s Men’s Weight-Loss Program

·

Review Strut’s Women’s Weight-Loss Program

Affiliate disclosure: Care Path Compare may receive compensation if you use a Strut Health link and make a purchase, at no extra cost to you. Compensation does not determine our editorial conclusions.

Strut Health weight loss at a glance

Question Current public information What to verify
Company structure Strut Health, LLC provides the non-clinical platform; Titan Health, P.A. and affiliates provide professional medical services Confirm the clinician and medical entity for your state
Clinician review Strut says a U.S.-licensed physician reviews the online visit and decides whether a prescription is appropriate An intake does not guarantee prescribing
Compounded semaglutide Oral lozenges and injections are currently advertised Confirm exact formulation, route, concentration, pharmacy, and medical-necessity basis
Compounded tirzepatide Oral lozenges and injections are currently advertised Confirm exact formulation, route, concentration, pharmacy, and medical-necessity basis
Lowest advertised starting price $99 auto-refill starting price for oral compounded semaglutide This is not a universal Strut weight-loss price
Insurance Strut’s FAQ says the service does not accept insurance Confirm whether any outside pharmacy or branded-drug pathway changes the cash price
Pharmacy Current pages describe a U.S.-licensed pharmacy network but do not name the dispenser for an individual order Ask for the legal pharmacy name and license before fulfillment
Follow-up Strut advertises physician messaging and follow-up care Confirm expected response time and visit format
Subscription Terms say prescriptions recur every 30 or 90 days depending on refill schedule Confirm the next charge and shipment date
Cancellation Current support says to request cancellation at least 48 hours before the scheduled shipment Save written cancellation confirmation
FDA history FDA issued Strut a warning letter on February 20, 2026 Current pages are clearer, but no FDA close-out letter was located as of August 7, 2026

Information and prices were checked August 7, 2026 and can change.

Is Strut Health legit?

The useful answer is more specific than a yes-or-no label.

Strut identifies a real business entity, a medical-services structure, a physical address, customer-support channels, subscription terms, and a telehealth workflow. Its Terms and Conditions say Strut Health, LLC controls the non-clinical site and services while Titan Health, P.A. and affiliated entities provide professional medical services through physicians.

That does not remove the need for due diligence. FDA issued Strut a warning letter in February 2026 concerning the way compounded semaglutide and tirzepatide were labeled and marketed. The letter is material regulatory history and should be part of a consumer’s evaluation.

Current Strut weight-loss pages now explicitly state that compounded medications are not FDA-approved and may differ from FDA-approved manufactured medications. We did not locate an FDA close-out letter confirming formal resolution of the warning-letter matter as of August 7, 2026.

So the practical question is not simply whether Strut exists. It is whether the specific prescription, dispensing pharmacy, formulation, recurring price, state availability, and cancellation terms are clear enough for the consumer before payment and shipment.

How the Strut weight-loss program works

Strut describes a three-part telehealth process:

  1. Select a treatment pathway and complete an online health questionnaire.
  2. Have a U.S.-licensed physician review the submitted information and decide whether prescribing is appropriate.
  3. If a prescription is issued, use Strut’s pharmacy network or, on at least some pages, choose to send the prescription to a local pharmacy.

Strut also advertises physician messaging, free follow-up care, and free shipping for eligible orders.

The initial online questionnaire is not a prescription guarantee. A licensed clinician is responsible for determining whether any treatment is appropriate, and product availability can depend on location, medical circumstances, and pharmacy fulfillment.

What weight-loss medications does Strut advertise?

The current weight-loss page reviewed August 7 lists four principal compounded pathways.

Oral compounded semaglutide

Strut advertises once-daily compounded semaglutide lozenges intended to dissolve in the mouth. The page describes the product as requiring medical necessity and shows an auto-refill starting price of $99.

This is not the same dosage form as an FDA-approved semaglutide tablet, and evidence or administration instructions for an FDA-approved branded oral product should not automatically be transferred to a compounded lozenge.

Injectable compounded semaglutide

Strut advertises once-weekly compounded semaglutide injections with an auto-refill starting price of $149. The current product page says compounded prescriptions are used only when the physician determines they are medically necessary and says compounded medications may differ from approved manufactured products in strength, route, packaging, dose, or other variables.

Review Strut’s Oral Semaglutide Pathway

·

Review Strut’s Compounded Semaglutide Pathway

Affiliate disclosure: These are affiliate links. Eligibility, prescribing, formulation, pharmacy fulfillment, and final price remain subject to clinician review and the provider’s current terms.

Oral compounded tirzepatide

Strut advertises compounded tirzepatide lozenges with an auto-refill starting price of $199. The category page says this pathway is only available for patients who fail or cannot use a GLP-1 injection and requires medical necessity.

There is no FDA-approved oral tirzepatide product that makes a compounded lozenge interchangeable with a branded medication. Consumers should ask what evidence supports the exact prescribed route and formulation.

Injectable compounded tirzepatide

Strut also advertises compounded tirzepatide injections. The current product page contains two different price presentations: an auto-refill price “as low as” $199 and a separate transparent-pricing section showing $325 for a 30-day supply.

That is a meaningful pricing discrepancy. A consumer should rely on the final checkout and prescription-specific price rather than assuming the lowest headline applies to every order.

Strut Health pricing in 2026

The current public weight-loss pages display the following headline figures:

Advertised pathway Current visible price Important qualification
Oral compounded semaglutide From $99 on auto-refill Starting price; prescription and medical necessity required
Injectable compounded semaglutide From $149 on auto-refill Starting price; prescription and medical necessity required
Oral compounded tirzepatide From $199 on auto-refill Starting price; product-specific eligibility language applies
Injectable compounded tirzepatide From $199 on auto-refill; another section shows $325 for 30 days Confirm the actual price before payment because the same page shows different figures

These are advertised figures, not guaranteed prices for every person. Medication, formulation, refill interval, pharmacy choice, and current promotion can change what is actually charged.

Strut’s injectable product pages say provider care and medication are included, with free follow-ups and shipping. The injectable semaglutide page also says users may be shown medication pricing through a pharmacy network and may choose a local pharmacy instead. That makes the final prescription and pharmacy route especially important when comparing total cost.

Use our online GLP-1 program cost guide to compare introductory prices, recurring prices, medication inclusion, shipping, and separate fees consistently.

What the price appears to include

Current weight-loss product pages commonly advertise:

  • the online physician visit;
  • medication for certain advertised compounded pathways when prescribed;
  • follow-up care;
  • physician messaging or access;
  • shipping; and
  • recurring refill service.

Public pages do not clearly establish one universal laboratory policy for every GLP-1 pathway. Before paying, ask whether laboratory testing is required for the specific prescription, who orders it, where it can be completed, and whether the cost is separate.

Clinician access and follow-up care

Strut says its medical platform uses U.S.-licensed physicians. The FAQ says patients can message physicians through their account and can arrange phone or video communication. The broader site also describes follow-up care as included.

That is more than a one-time checkout model, but public pages do not guarantee a specific response time or number of synchronous appointments. Consumers who expect scheduled visits should confirm what ongoing access actually looks like for the weight-loss program before enrolling.

Pharmacy transparency

This is an area where additional confirmation is worthwhile.

Strut’s current injectable semaglutide page says it works with U.S.-licensed compounding pharmacies and that the user can see medication pricing through its pharmacy network. The page also says a prescription can be sent to a local pharmacy instead.

The weight-loss product pages we reviewed do not identify the legal name of the pharmacy that would dispense a particular compounded prescription.

Before fulfillment, ask for:

  • the pharmacy’s legal name and physical location;
  • the state license relevant to the shipment destination;
  • whether it operates under a 503A or other applicable compounding pathway;
  • the exact active ingredient and formulation;
  • the concentration and dosing units on the prescription label;
  • storage and shipping instructions; and
  • whom to contact about a damaged or temperature-exposed shipment.

A statement that a pharmacy network is U.S.-licensed is not a substitute for verifying the actual dispenser assigned to the order.

State availability is not clear enough for a permanent list

Strut’s current FAQ still contains a statement saying that, as of September 2024, it could ship to all states except Arkansas. The same answer immediately cautions that certain medications may not be available in all states.

Because that geographic statement is dated and product availability can vary, Care Path Compare is not treating it as a current nationwide treatment list in August 2026.

Before payment, confirm that the exact weight-loss medication and dosage form are available in the consumer’s state, that the reviewing clinician is appropriately licensed, and that the assigned pharmacy can lawfully dispense and ship the prescription there.

The February 2026 FDA warning letter

FDA issued Strut Health, LLC dba Strut a warning letter dated February 20, 2026 after reviewing the company’s website in December 2025.

FDA identified two central issues relevant to consumers comparing compounded GLP-1 programs:

  1. FDA said product-label imagery displayed the Strut name in a way that suggested Strut itself was the compounder when FDA stated it was not.
  2. FDA cited marketing language, including the phrase “Generic Zepbound, Mounjaro,” and other claims that FDA said implied the compounded semaglutide and tirzepatide products were FDA-approved or otherwise evaluated for safety and effectiveness when they were not.

FDA characterized those representations as false or misleading and said the products were misbranded under the cited provisions of the Federal Food, Drug, and Cosmetic Act. The agency asked Strut to respond within 15 working days with corrective steps, including identification of the actual compounders and changes addressing misleading website claims.

The warning letter should not be converted into a broader claim that every current Strut service or prescription is unlawful or illegitimate. It does establish a documented regulatory issue that consumers deserve to know about.

What appears to have changed since the FDA letter

Current Strut product pages use materially clearer compounded-drug language than the claims FDA quoted from the December 2025 site.

The current injectable semaglutide page states that compounded medications are not FDA-approved and may differ from approved manufactured medications in strength, route, packaging, dose, or other variables. Current weight-loss pages also use medical-necessity language rather than presenting compounded drugs as interchangeable generic versions of branded products.

Those current disclosures are relevant improvements in public wording. They are not the same as an FDA close-out letter. A search of FDA’s public materials did not locate a Strut close-out letter as of August 7, 2026, so Care Path Compare is not describing the matter as formally resolved.

Subscription, cancellation, and refund terms

Strut’s Terms and Conditions say prescriptions are subscriptions. The customer is charged the full prescription amount every 30 or 90 days, depending on the refill schedule, until the subscription is paused or canceled.

Current Strut support pages provide a concrete timing rule: contact the Strut Care Team at least 48 hours before the next scheduled shipment to help ensure a cancellation or suspension is processed before shipment.

The return and cancellation pages also state:

  • once a refill has been dispatched from the pharmacy, Strut cannot issue a refund; and
  • prescription medication that has left the pharmacy cannot be returned or refunded.

So “cancel anytime” should not be interpreted as “refund anytime.” A consumer should identify the next scheduled shipment, submit the request before the 48-hour cutoff, and retain written confirmation.

Review our GLP-1 cancellation, renewal, and refund guide before enrolling in any recurring program.

Potential advantages to compare

Based on the public program structure—not treatment outcomes—Strut has several features worth comparing with other telehealth programs:

  • several oral and injectable compounded pathways are displayed in one weight-loss category;
  • starting prices are visible before the full medical intake;
  • the company describes U.S.-licensed physician review;
  • physician messaging and follow-up care are advertised;
  • shipping is advertised as included for applicable orders; and
  • subscription cancellation instructions and a 48-hour timing rule are publicly available.

These features do not establish that Strut is medically appropriate for a particular person or that the lowest advertised price will apply.

Important limitations

The main limitations we would verify before paying are:

  • Regulatory history: FDA issued the February 2026 warning letter, and no public close-out letter was located during this review.
  • Compounded products: the semaglutide and tirzepatide formulations discussed here are not FDA-approved.
  • Oral formulations: compounded lozenges should not be treated as equivalent to approved injectable or branded oral products.
  • Pharmacy transparency: the reviewed weight-loss pages do not name the actual dispensing pharmacy before assignment.
  • Pricing consistency: the injectable tirzepatide page simultaneously shows an auto-refill price as low as $199 and a $325 30-day-supply figure.
  • State availability: the FAQ’s broad shipping statement is dated September 2024 and also says medication availability varies.
  • Laboratory policy: public GLP-1 pages do not clearly establish one complete lab-testing and lab-cost policy.

Who may find Strut worth comparing?

Strut may be worth researching for adults comparing cash-pay telehealth programs that offer multiple compounded weight-loss formulations, online physician review, ongoing messaging, and recurring home delivery.

It may require more due diligence for someone who wants a named dispensing pharmacy before checkout, needs a precise current state-availability list, wants a single unambiguous price for injectable tirzepatide, or prefers an FDA-approved branded medication rather than a compounded formulation.

A licensed clinician should determine whether any prescription treatment is appropriate.

Questions to ask before paying

  1. What exact medication, dosage form, concentration, and route would be prescribed if I am eligible?
  2. Why is a compounded product medically necessary in my situation, if that is the proposed pathway?
  3. Which legal pharmacy will dispense the prescription, and where is it licensed?
  4. What is the exact amount charged today?
  5. What will the next 30- or 90-day renewal cost?
  6. Does the quoted amount include medication, clinician review, follow-up care, and shipping for my specific prescription?
  7. Are laboratory tests required, and are they included?
  8. Is this medication and formulation currently available in my state?
  9. What is my next scheduled shipment date?
  10. By what date and time must I cancel to avoid the next shipment?
  11. What happens financially if the clinician does not prescribe the selected treatment?
  12. What should I do if a compounded shipment arrives damaged or outside expected storage conditions?

Use the provider-verification checklist to document the answers before enrollment.

Bottom line

Strut Health has enough identifiable business, clinical-process, pricing, and policy information to merit a dedicated consumer review. Current pages clearly distinguish compounded products from FDA-approved drugs more carefully than the language FDA cited in its February 2026 warning letter.

The strongest reasons for additional verification are the unresolved public FDA close-out status, unnamed dispensing pharmacy on the reviewed weight-loss pages, dated state-availability language, and inconsistent visible pricing for compounded injectable tirzepatide.

For a consumer comparing Strut with other online programs, the most useful next step is to verify the exact prescription, pharmacy, recurring price, state availability, and cancellation cutoff rather than relying on a headline starting price.

Review Strut’s Current Weight-Loss Program

· Compare online GLP-1 programs · Compare total program costs

Affiliate disclosure: Care Path Compare may receive compensation if you use the Strut Health link and make a purchase, at no extra cost to you. Compensation does not determine our editorial conclusions.

Frequently asked questions

Is Strut Health a real telehealth company?

Strut Health, LLC identifies itself in its current Terms and Conditions and lists Titan Health, P.A. and affiliated entities as the professional medical-service providers. Consumers should still verify the specific clinician, pharmacy, medication, pricing, and state availability tied to an individual order.

Did FDA issue Strut Health a warning letter?

Yes. FDA issued Strut Health, LLC dba Strut a warning letter dated February 20, 2026 concerning false or misleading labeling and marketing of compounded semaglutide and tirzepatide. Current Strut pages contain clearer compounded-drug disclosures, but Care Path Compare did not locate an FDA close-out letter as of August 7, 2026.

How much does Strut Health semaglutide cost?

Strut’s current weight-loss category advertises oral compounded semaglutide from $99 on auto-refill and injectable compounded semaglutide from $149 on auto-refill. These are starting prices, not universal quotes. Confirm the final prescription, pharmacy route, renewal price, and included services before paying.

How much does Strut Health tirzepatide cost?

The current category page advertises oral compounded tirzepatide from $199. The injectable tirzepatide product page shows an auto-refill price as low as $199 but also displays $325 for a 30-day supply. Because those figures are not fully aligned, confirm the actual checkout price before enrollment.

Does Strut Health use compounded medication?

Yes. Current weight-loss pages advertise compounded semaglutide and tirzepatide in oral and injectable forms. Compounded medications are not FDA-approved and should not be described as generic or equivalent versions of FDA-approved products.

Which pharmacy does Strut Health use?

The weight-loss pages reviewed describe a network of U.S.-licensed compounding pharmacies but do not identify the dispenser for an individual prescription. Ask for the legal pharmacy name and verify its state license before fulfillment.

Can I cancel Strut Health anytime?

Strut says subscriptions may be canceled, but its current support guidance asks customers to submit cancellation or suspension requests at least 48 hours before the next scheduled shipment. Once medication has been dispatched from the pharmacy, Strut says it cannot issue a refund.

Official sources